CHJTF (CSPC Pharmaceutical Group) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHJTF CSPC Pharmaceutical Group Ltd CHJTF
55 GF Score
Price $1.11
GF Value $1.15
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group 3-Month Share Buyback Ratio?

CSPC Pharmaceutical Group CHJTF 55 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates CHJTF with a GF Score™ of 55/100 and a GF Value™ of $1.15 (Fairly Valued). The stock has 3 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

CHJTF
55GF Score
CSPC Pharmaceutical Group Ltd CHJTF
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
CSPC Pharmaceutical Group (CHJTF) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for CSPC Pharmaceutical Group and its competitors.
Is CSPC Pharmaceutical Group's 3-Month Share Buyback Ratio too high?
CSPC Pharmaceutical Group's current 3-Month Share Buyback Ratio is 0.00. Overall, CSPC Pharmaceutical Group has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's 3-Month Share Buyback Ratio compare to LLY and JNJ?
CSPC Pharmaceutical Group's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Drug Manufacturers company?
A good 3-Month Share Buyback Ratio depends on the Drug Manufacturers industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for CSPC Pharmaceutical Group and its competitors. CSPC Pharmaceutical Group's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group (CHJTF) is currently considered Fairly Valued. The stock's GF Value™ is $1.15, compared to a current price of $1.11 — trading 3.5% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. CSPC Pharmaceutical Group's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For CSPC Pharmaceutical Group (CHJTF), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSPC Pharmaceutical Group (CHJTF) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be undervalued. The current stock price of $1.11 is trading 3.5% below its estimated GF Value™ of $1.15. GuruFocus considers CSPC Pharmaceutical Group to be Fairly Valued.

Key valuation signals for CHJTF:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: $1.15 vs. price of $1.11 (3.5% below fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the CHJTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
55GF Score

Get the complete analysis for CHJTF

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.11
Price
$1.15
GF Value